CVE-2021-43935

ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products

Description

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.

Remediation

Solution:

  • Hillrom recommends users upgrade to the latest product versions when updated products are available. Information on how to update these products to their new versions can be found on the Hillrom disclosure page.

Workaround:

  • -Disable the SSO feature in the respective Modality Manager Configuration settings. Please refer to the instructions for use (IFU) and/or service manual for instructions on how to disable SSO. -Apply proper network and physical security controls. -Apply authentication for server access.

Categories

8.1
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.19%
Third-Party Advisory cisa.gov
Affected: Hillrom Welch Allyn Q-Stress Cardiac Stress Testing System
Affected: Hillrom Welch Allyn X-Scribe Cardiac Stress Testing System
Affected: Hillrom Welch Allyn Diagnostic Cardiology Suite
Affected: Hillrom Welch Allyn Vision Express
Affected: Hillrom Welch Allyn H-Scribe Holter Analysis System
Affected: Hillrom Welch Allyn R-Scribe Resting ECG System
Affected: Hillrom Welch Allyn Connex Cardio
Published at:
Updated at:

References

Link Tags
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 mitigation third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2021-43935?
CVE-2021-43935 has been scored as a high severity vulnerability.
How to fix CVE-2021-43935?
To fix CVE-2021-43935: Hillrom recommends users upgrade to the latest product versions when updated products are available. Information on how to update these products to their new versions can be found on the Hillrom disclosure page.
Is CVE-2021-43935 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2021-43935 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-43935?
CVE-2021-43935 affects Hillrom Welch Allyn Q-Stress Cardiac Stress Testing System, Hillrom Welch Allyn X-Scribe Cardiac Stress Testing System, Hillrom Welch Allyn Diagnostic Cardiology Suite, Hillrom Welch Allyn Vision Express, Hillrom Welch Allyn H-Scribe Holter Analysis System, Hillrom Welch Allyn R-Scribe Resting ECG System, Hillrom Welch Allyn Connex Cardio.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.